(1S,2R,3R,4S,5S,6S,8S,9S,10R,13S,16S,17R)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8-diol

Details

Top
Internal ID 128a35b2-b72a-4d69-a1b7-988a9c051e16
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Diterpenoids > Aconitane-type diterpenoid alkaloids
IUPAC Name (1S,2R,3R,4S,5S,6S,8S,9S,10R,13S,16S,17R)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8-diol
SMILES (Canonical) CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC
SMILES (Isomeric) CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2C[C@@H]([C@H]31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6O)OC)O)OC)COC
InChI InChI=1S/C24H39NO5/c1-5-25-11-22(12-28-2)7-6-18(30-4)24-14-8-13-16(29-3)10-23(27,19(14)20(13)26)15(21(24)25)9-17(22)24/h13-21,26-27H,5-12H2,1-4H3/t13-,14-,15+,16+,17-,18+,19-,20+,21-,22+,23+,24-/m1/s1
InChI Key BDCURAWBZJMFIK-OGVVJMRYSA-N
Popularity 12 references in papers

Physical and Chemical Properties

Top
Molecular Formula C24H39NO5
Molecular Weight 421.60 g/mol
Exact Mass 421.28282334 g/mol
Topological Polar Surface Area (TPSA) 71.40 Ų
XlogP 0.90
Atomic LogP (AlogP) 1.53
H-Bond Acceptor 6
H-Bond Donor 2
Rotatable Bonds 5

Synonyms

Top
Talatizamine
20501-56-8
C24-H39-N-O5
(1S,4S,5R,7S,8S,9R,10R, 11S,13S,14S,16S,17R)-N-methyl- 8,14-dihydroxy-1,16-trimethoxy-4-(methoxymethylene)aconitane

2D Structure

Top
2D Structure of (1S,2R,3R,4S,5S,6S,8S,9S,10R,13S,16S,17R)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8399 83.99%
Caco-2 - 0.5303 53.03%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5143 51.43%
Subcellular localzation Lysosomes 0.7408 74.08%
OATP2B1 inhibitior - 0.8583 85.83%
OATP1B1 inhibitior + 0.9263 92.63%
OATP1B3 inhibitior + 0.9434 94.34%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior + 0.5872 58.72%
P-glycoprotein inhibitior - 0.8949 89.49%
P-glycoprotein substrate + 0.6327 63.27%
CYP3A4 substrate + 0.6905 69.05%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate + 0.4514 45.14%
CYP3A4 inhibition - 0.9356 93.56%
CYP2C9 inhibition - 0.8984 89.84%
CYP2C19 inhibition - 0.8889 88.89%
CYP2D6 inhibition - 0.9224 92.24%
CYP1A2 inhibition - 0.9230 92.30%
CYP2C8 inhibition + 0.5847 58.47%
CYP inhibitory promiscuity - 0.9489 94.89%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6314 63.14%
Eye corrosion - 0.9871 98.71%
Eye irritation - 0.9039 90.39%
Skin irritation - 0.7772 77.72%
Skin corrosion - 0.9284 92.84%
Ames mutagenesis - 0.5970 59.70%
Human Ether-a-go-go-Related Gene inhibition + 0.6915 69.15%
Micronuclear - 0.5300 53.00%
Hepatotoxicity - 0.7366 73.66%
skin sensitisation - 0.8608 86.08%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.9625 96.25%
Nephrotoxicity - 0.7339 73.39%
Acute Oral Toxicity (c) III 0.4756 47.56%
Estrogen receptor binding + 0.7509 75.09%
Androgen receptor binding + 0.6858 68.58%
Thyroid receptor binding + 0.6742 67.42%
Glucocorticoid receptor binding + 0.5384 53.84%
Aromatase binding + 0.6770 67.70%
PPAR gamma + 0.6087 60.87%
Honey bee toxicity - 0.7873 78.73%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity - 0.6766 67.66%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.01% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 98.50% 97.25%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 97.39% 85.14%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 94.05% 96.38%
CHEMBL204 P00734 Thrombin 93.27% 96.01%
CHEMBL241 Q14432 Phosphodiesterase 3A 92.47% 92.94%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.42% 97.09%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 91.90% 95.58%
CHEMBL226 P30542 Adenosine A1 receptor 91.75% 95.93%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 90.77% 91.03%
CHEMBL221 P23219 Cyclooxygenase-1 90.33% 90.17%
CHEMBL1994 P08235 Mineralocorticoid receptor 89.63% 100.00%
CHEMBL1907601 P11802 Cyclin-dependent kinase 4/cyclin D1 87.64% 98.99%
CHEMBL5608 Q16288 NT-3 growth factor receptor 87.30% 95.89%
CHEMBL2534 O15530 3-phosphoinositide dependent protein kinase-1 86.26% 95.36%
CHEMBL2730 P21980 Protein-glutamine gamma-glutamyltransferase 85.01% 92.38%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 84.20% 95.17%
CHEMBL1871 P10275 Androgen Receptor 83.90% 96.43%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 83.32% 97.50%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 82.98% 97.14%
CHEMBL3820 P35557 Hexokinase type IV 82.28% 91.96%
CHEMBL2069156 Q14145 Kelch-like ECH-associated protein 1 82.28% 82.38%
CHEMBL5888 Q99558 Mitogen-activated protein kinase kinase kinase 14 81.97% 100.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.79% 95.89%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.65% 92.62%
CHEMBL3746 P80365 11-beta-hydroxysteroid dehydrogenase 2 81.52% 94.78%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 81.18% 89.62%
CHEMBL4073 P09237 Matrix metalloproteinase 7 81.11% 97.56%
CHEMBL259 P32245 Melanocortin receptor 4 80.85% 95.38%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.39% 94.45%
CHEMBL2781 P19634 Sodium/hydrogen exchanger 1 80.32% 90.24%
CHEMBL279 P35968 Vascular endothelial growth factor receptor 2 80.32% 95.52%
CHEMBL2581 P07339 Cathepsin D 80.23% 98.95%

Cross-Links

Top
PubChem 57506227
NPASS NPC205595
LOTUS LTS0086498
wikiData Q104923925